PhaseV, a leader in AI/ML-driven clinical development, today announced a strategic partnership with the Crohn's & Colitis ...

Clinical characterization and therapeutic outcomes of patients (pts) with colorectal cancer (CRC) harboring somatic BRCA1/2 mutations. A phase II trial of TAS-102 in patients with colorectal cancer ...

Fight Dengue campaign, Civil Surgeon Dr Sangeeta Jain visited various places in district today. Along with a team of senior ...

Results from the randomized phase 3 DREAMM-8 study of belantamab mafodotin plus pomalidomide and dexamethasone (BPd) vs pomalidomide plus bortezomib and dexamethasone (PVd) in relapsed/refractory ...

Abstract: This paper presents a 28-GHz CMOS four-element phased-array transceiver chip for the fifth-generation mobile network (5G) new radio (NR). The proposed transceiver is based on the ...

Buffalo Mayor Chris Scanlon announced on Monday the completion of Phase IV of the Niagara Street Streetscape Project, while ...

Lucknow: A seven-member delegation of women police officers from Uttar Pradesh showcased the state's flagship Mission Shakti Scheme as a model for pro.

rNIHR UCLH Clinical Research Facility and NIHR UCLH Biomedical Research Centre, University College London Hospitals NHS Foundation Trust, London, UK sUniversity Hospitals Sussex NHS Foundation Trust, ...

PhaseV Inc. raised $50 million in a series A funding round to further develop its machine learning (ML) platform which helps companies reduce the cost and duration of clinical trials, and increase ...

With a Growing List of 30+ Global Customers, Including Top Pharma, PhaseV is Poised to Transform Clinical Development at Scale with its Vertical AI Platform BOSTON, May 13, 2025 /PRNewswire/ -- PhaseV ...

With a Growing List of 30+ Global Customers, Including Top Pharma, PhaseV is Poised to Transform Clinical Development at Scale with its Vertical AI Platform BOSTON, May 13, 2025 /PRNewswire ...